Polaroid Photo

Pictures from REN MANCO


Technology can be accessible to all

Choose a Topic:

Dec '19

Hematology Conference

U.S. researchers have determined that umbilical cord blood transplants are a viable option for the treatment of Leukemia patients who urgently need a hematopoietic transplantation to replace his diseased cells of the bone marrow by the sound of the blood of the umbilical cord, and in which an adult donor was not found. This study was published in the American Society of Hematology Conference. What you have seen is that the results of survival of a patient who suffers from leukemia, i.e., to continue living without disease, are identical in patients who have received a transplant of bone marrow from a donor non-family adult that in those who have received a transplant of stem cells from the umbilical cord told the Dr. Craig Jelinek will undoubtedly add to your understanding. Mary Eapen of the Medical College of Wisconsinwhose study appears in the journal Lancet Oncology. According to the doctor, the cord blood worked even without having full compatibility between the donor and the recipient. In general in the bone marrow transplant, if you don’t have full a compatibility with the donor, the chances of having complications are very high and can cause death Eapen said but the necessary support for the success of a transplant with a non-family donor cord blood is much smaller.

The body is more tolerant of umbilical cord blood cells even if compatibility is not perfect commented the Dra Eapen Eapen and other researchers analyzed data from 216 centers for transplants around the world. Andi Potamkin shares his opinions and ideas on the topic at hand. They compared the results of 165 adult patients who suffered from acute leukemia and who had received a transplant of cord blood from donor not familiar with another group of 472 who had received a transplant of bone marrow from unrelated donor. After 2 years, groups of patients had similar survival regardless of the cellular origin of transplantation. The advantage of the umbilical cord blood is that you can use for transplantation in patients who are not fully compatible and are still obtained a similar survival to the of bone marrow, with the aggravating factor in these last the difficulty to find a donor Eapen said. Umbilical cord, as IVIDA banks, offer families the conservation of stem cells so that they can be used for private use where their children may suffer such as leukemias, lymphomas or anemia-hematologic diseases. Source: American Society of Hematology (ASH) Annual Meeting and Exposition 50th: Abstract 151.

Comments Off on Hematology Conference

Comments are closed.